A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions

Por Xu, Ronald X, Young, Donn C, Mao, Jimmy J, Povoski, Stephen P
Publicado em 2007

Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma

Por Horvath, James W, Barnett, Gary E, Jimenez, Rafael E, Young, Donn C, Povoski, Stephen P
Publicado em 2009

A Folate- and Methyl-Deficient Diet Alters the Expression of DNA Methyltransferases and Methyl CpG Binding Proteins Involved in Epigenetic Gene Silencing in Livers of F344 Rats

Por Ghoshal, Kalpana, Li, Xin, Datta, Jharna, Bai, Shoumei, Pogribny, Igor, Pogribny, Marta, Huang, Yan, Young, Donn, Jacob, Samson T.
Publicado em 2006

Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery

Por Povoski, Stephen P, Young, Donn C, Walker, Michael J, Carson, William E, Yee, Lisa D, Agnese, Doreen M, Farrar, William B
Publicado em 2007

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab

Por Mani, Aruna, Roda, Julie, Young, Donn, Caligiuri, Michael A., Fleming, Gini F., Kaufman, Peter, Brufsky, Adam, Ottman, Susan, Carson, William E., Shapiro, Charles L.
Publicado em 2008

Psychologic Intervention Improves Survival for Breast Cancer Patients: A Randomized Clinical Trial

Por Andersen, Barbara L., Yang, Hae-Chung, Farrar, William B., Golden-Kreutz, Deanna M., Emery, Charles F., Thornton, Lisa M., Young, Donn C., Carson, William E.
Publicado em 2008

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma

Por Lustberg, Maryam B., Bekaii-Saab, Tanios, Young, Donn, Otterson, Gregory, Burak, William, Abbas, Abbas, McCracken-Bussa, Barbara, Lustberg, Mark E., Villalona-Calero, Miguel A.
Publicado em 2010

Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)

Por Kraut, Eric H., Rhoades, Christopher, Zhang, Yilong, Cheng, Hao, Aimiumu, Josephine, Chen, Ping, Lang, James, Young, Donn C., Agrawal, Amit, Dancey, Janet, Chan, Kenneth K., Grever, Michael R.
Publicado em 2010

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

Por Bekaii-Saab, Tanios S., Roda, Julie M., Guenterberg, Kristan D., Ramaswamy, Bhuvanaswari, Young, Donn C., Ferketich, Amy K., Lamb, Tammy A., Grever, Michael R., Shapiro, Charles L., Carson, William E.
Publicado em 2009

Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance

Por Tseng, Ping-Hui, Lin, Ho-Pi, Zhu, Jiuxiang, Chen, Kuen-Feng, Hade, Erinn M., Young, Donn C., Byrd, John C., Grever, Michael, Johnson, Kara, Druker, Brian J., Chen, Ching-Shih
Publicado em 2005

A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors

Por Ramaswamy, Bhuvaneswari, Bekaii-Saab, Tanios, Schaaf, Larry J., Lesinski, Gregory B., Lucas, David M., Young, Donn C., Ruppert, Amy S., Byrd, John C., Culler, Kristy, Wilkins, Diedre, Wright, John J., Grever, Michael R., Shapiro, Charles L.
Publicado em 2009

Validation of an LC-MS Based Approach for Profiling Histones in Chronic Lymphocytic Leukemia

Por Su, Xiaodan, Lucas, David M., Zhang, Liwen, Xu, Hua, Zabrouskov, Vlad, Davis, Melanie E., Knapp, Amy R., Young, Donn C., Payne, Philip R.O., Parthun, Mark R., Marcucci, Guido, Grever, Michael R., Byrd, John C., Freitas, Michael A.
Publicado em 2009

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia

Por Byrd, John C., Lin, Thomas S., Dalton, James T., Wu, Di, Phelps, Mitch A., Fischer, Beth, Moran, Mollie, Blum, Kristie A., Rovin, Brad, Brooker-McEldowney, Michelle, Broering, Sarah, Schaaf, Larry J., Johnson, Amy J., Lucas, David M., Heerema, Nyla A., Lozanski, Gerard, Young, Donn C., Suarez, Jose-Ramon, Colevas, A. Dimitrios, Grever, Michael R.
Publicado em 2007